MDG Forum: Monitoring and Improving Health and Aging in Place
When
December 3, 2018
5:30 - 8:30 PM
Where
Regis College Fine Arts Center
Weston,
MA
Medical Development Group Boston hosted their December forum event on December 3rd, 2018, titled, "Monitoring and Improving Health and Aging in Place." This session reviewed various new monitoring and mobile technologies that will allow more people (including children, chronic disease patients and frail elders) to be treated more humanely and cost effectively at home.
For more information, please visit MDG's website.
Hamilton Brook Smith Reynolds is a proud sponsor of The Medical Development Group Boston. MDG is a community of individuals professionally committed to the Medical Device and other Medical Technology Industry segments united by the belief that innovation and advances in technology lead to substantial improvements in health care.
 | Anna Barry, Ph.D. Dr. Barry brings to Jounce more than 15 years of intellectual property, corporate and transactional legal experience in the biotechnology industry. Prior to joining Jounce Therapeutics, Dr. Barry was senior intellectual property counsel at Five Prime Therapeutics, where she managed all aspects of intellectual property related to the company’s therapeutic pipeline and platform technology.
|
 | Aaron Schwartz Aaron has been a Director in Novo Nordisk’s Search & Evaluation team in Global Drug Discovery since 2016. Aaron is responsible for the search and evaluation of new therapeutics and enabling technologies for protein, peptide, and antibody drugs. Prior to joining Novo Nordisk, Aaron worked in the MIT Technology Licensing Office for 13.5 years.
|
 | Lauren Foster Director of IP and Strategic Alliances at Koch Institute. Medicine, Cell Biology, Biotechnology, Diagnostics.
|
 | Dr. Jack Salerno Over 25 years’ experience in corporate operations, product development and product commercialization with a career spanning R&D management to corporate CEO in high tech microsystems. Jack is also an EVP at Triton Systems having earlier held title of President at Agiltron and VP at Kopin Corporation, where he established one of the first compound semiconductor epitaxial wafer businesses.
|
 | Deirdre Sanders Deirdre has 20 years of experience in strategic biotechnology patent prosecution counseling and in intellectual property litigation and enforcement. Deirdre’s patent practice is focused in the field of biotechnology with a particular emphasis in the areas of biologics including antibody-based therapeutics, pharmaceuticals, medical devices, immuno-oncology and immunotherapy, bioinformatics, protein-based sensors, and drug discovery and development.
|
|
| Mark Solomon Mark has dedicated his 19-year legal career to guiding engineering companies and university engineering centers through the development, management, protection, and enforcement of intellectual property rights. He provides high value IP services for clients who value IP by drafting and prosecuting patent applications from strategic business or licensing perspectives, as applicable.
|
